These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2028830)

  • 21. Ritalin for nicotine withdrawal: Nesbitt's paradox revisited.
    Robinson MD; Anastasio GD; Little JM; Sigmon JL; Menscer D; Pettice YJ; Norton HJ
    Addict Behav; 1995; 20(4):481-90. PubMed ID: 7484329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bupropion for the treatment of nicotine withdrawal and craving.
    Mooney ME; Sofuoglu M
    Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation.
    Prochazka AV; Petty TL; Nett L; Silvers GW; Sachs DP; Rennard SI; Daughton DM; Grimm RH; Heim C
    Arch Intern Med; 1992 Oct; 152(10):2065-9. PubMed ID: 1417380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of sustained-release bupropion and placebo for smoking cessation.
    Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
    N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.
    Ebbert JO; Dale LC; Patten CA; Croghan IT; Schroeder DR; Moyer TP; Hurt RD
    Nicotine Tob Res; 2007 Jan; 9(1):43-52. PubMed ID: 17365735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline.
    Steinberg MB; Randall J; Greenhaus S; Schmelzer AC; Richardson DL; Carson JL
    Addict Behav; 2011 Dec; 36(12):1127-32. PubMed ID: 21835552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks' treatment with diazepam or buspirone.
    Murphy SM; Owen R; Tyrer P
    Br J Psychiatry; 1989 Apr; 154():529-34. PubMed ID: 2686797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity.
    Piasecki TM; Jorenby DE; Smith SS; Fiore MC; Baker TB
    Exp Clin Psychopharmacol; 2003 Nov; 11(4):276-85. PubMed ID: 14599261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale.
    Cappelleri JC; Bushmakin AG; Baker CL; Merikle E; Olufade AO; Gilbert DG
    Curr Med Res Opin; 2005 May; 21(5):749-60. PubMed ID: 15969874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term treatment with aripiprazole on the waking and postprandial urges to smoke in Chinese heavy smokers.
    Liu Y; Bao YP; Sun HQ; Beveridge TJ; Li SX; Di XL; Yang FD; Lu L
    J Clin Psychopharmacol; 2010 Aug; 30(4):373-80. PubMed ID: 20631555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
    Rose JE; Behm FM; Ramsey C; Ritchie JC
    Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement.
    McRobbie H; Hajek P
    Hum Psychopharmacol; 2004 Jan; 19(1):57-61. PubMed ID: 14716714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of buspirone in withdrawal from opiates.
    Rose JS; Branchey M; Wallach L; Buydens-Branchey L
    Am J Addict; 2003; 12(3):253-9. PubMed ID: 12851021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buspirone in social phobia.
    Schneier FR; Saoud JB; Campeas R; Fallon BA; Hollander E; Coplan J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Aug; 13(4):251-6. PubMed ID: 8376612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiety and smoking cessation outcomes in alcohol-dependent smokers.
    Kelly MM; Grant C; Cooper S; Cooney JL
    Nicotine Tob Res; 2013 Feb; 15(2):364-75. PubMed ID: 22955245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A preliminary investigation into the effects of doxazosin on cognitive functioning in tobacco-deprived and -satiated smokers.
    Roberts W; Verplaetse TL; Moore KE; Oberleitner LM; McKee SA
    Hum Psychopharmacol; 2018 May; 33(3):e2660. PubMed ID: 29878501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.